12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Biomerica (BMRA) saw a 71.7% increase, while Arcutis Biotherapeutics (ARQT) rose by 41.8%. Alaunos Therapeutics (TCRT), Akili (AKLI), Applied DNA Sciences (APDN), and NRX Pharmaceuticals (NRXP) also gained. Conversely, Minerva Surgical (UTRS) dropped by 53.9%, Checkpoint Therapeutics (CKPT) by 49.7%, Structure Therapeutics (GPCR) by 40.96%, Blue Water Biotech (BWV) by 16.88%, Lantheus Holdings (LNTH) by 15.84%, and Lantern Pharma (LTRN) by 13.01%.
December 18, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Checkpoint Therapeutics saw a pre-market decline of 49.7%, which could be due to negative developments or investor concerns.
The significant drop in Checkpoint Therapeutics' stock price may be attributed to negative company news or broader market concerns, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Structure Therapeutics' shares fell by 40.96% in pre-market trading, suggesting a strong bearish outlook from investors.
The substantial pre-market drop in Structure Therapeutics' stock price could reflect investor reaction to negative news or disappointing results, which may lead to continued selling pressure in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Minerva Surgical's stock plummeted by 53.9% in pre-market trading, indicating negative investor sentiment or reactions to adverse news.
The sharp decline in Minerva Surgical's stock price suggests that investors may be reacting to negative news or poor company performance, which could lead to further short-term downside.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Arcutis Biotherapeutics experienced a significant pre-market increase of 41.8%, reflecting potential positive news or investor confidence.
The large pre-market jump in Arcutis Biotherapeutics' stock price could be due to positive news or developments that have yet to be fully disclosed, suggesting a possible continuation of this trend in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Biomerica's stock rose sharply by 71.7% in pre-market trading, indicating a strong positive investor sentiment.
The substantial pre-market gain for Biomerica suggests a positive development or investor sentiment that could lead to increased trading volume and continued upward price movement in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100